10例髓细胞肉瘤的临床分析

发布时间：2018-05-29 04:48

本文选题：髓细胞肉瘤 + 临床特点　；参考：《肿瘤防治研究》2017年06期

【摘要】：目的探讨髓细胞肉瘤的临床特点及其预后。方法回顾性分析2001年至2014年北京大学第三医院血液科收治10例髓细胞肉瘤患者的资料,对其临床特点及预后进行总结。结果 10例患者中女性6例,男性4例,中位发病年龄为40.5岁,受累部位包括皮肤、乳腺、淋巴结、胸骨周围、宫颈、支气管,均接受化疗为主的治疗,5例死亡。中位生存期为12月,自诊断髓细胞肉瘤之日算起,最长存活240月。结论髓细胞肉瘤是一种罕见的局限性肿瘤,系统性化疗应在疾病确诊后尽快使用,造血干细胞移植可改善不良预后。
[Abstract]:Objective to investigate the clinical features and prognosis of myelocytic sarcoma. Methods the data of 10 cases of myelocytic sarcoma treated in hematology department of the third Hospital of Peking University from 2001 to 2014 were analyzed retrospectively and their clinical characteristics and prognosis were summarized. Results among the 10 patients, 6 were female and 4 were male. The median age of onset was 40.5 years old. The affected areas included skin, mammary gland, lymph nodes, sternum, cervix and bronchus. The median survival time was 12 months, and the longest survival time was 240 months from the date of diagnosis of medullary sarcoma. Conclusion Myelocytic sarcoma is a rare localized tumor, systemic chemotherapy should be used as soon as possible after the diagnosis of the disease, hematopoietic stem cell transplantation can improve the poor prognosis.
【作者单位】：北京大学第三医院血液科;
【基金】：北京市自然科学基金(7132183)
【分类号】：R733

【相似文献】